GlaxoSmithKline plc (ADR) (NYSE:GSK)

CAPS Rating: 4 out of 5

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.


Player Avatar PsychoDr (93.56) Submitted: 1/15/2013 12:05:15 PM : Outperform Start Price: $40.24 GSK Score: -20.12

Health care industry, 5.28% dividend, low dividend payout percent, history of growing dividend, pharmaceutical with a reasonable pipeline. Depressed earnings due to European crisis and a couple drugs coming off patent protection. Prognosticators are expecting flat earnings for the next two years. With a dividend reinvest position, flat earnings are fine by me. Can yo say cash cow? Share acquisition time people.

Featured Broker Partners